NeuroMetrix

NeuroMetrix, Inc. is a healthcare company specializing in the detection, diagnosis, and monitoring of peripheral nerve and spinal cord disorders, with a particular focus on diabetic neuropathies. The company develops and markets wearable neuro-stimulation devices and point-of-care diagnostic tests aimed at addressing chronic health conditions such as chronic pain, sleep disorders, and diabetes. Its product offerings include Quell, a device designed for chronic pain relief; DPNCheck, a diagnostic test for diabetic peripheral neuropathy; the ADVANCE system for traditional nerve conduction studies; and SENSUS, a therapy device utilizing transcutaneous electrical nerve stimulation. NeuroMetrix serves a diverse customer base, including health care professionals, managed care organizations, and various medical specialists. The company operates in multiple regions, including the United States, Europe, Japan, China, the Middle East, and Mexico, and has established a strategic collaboration with GlaxoSmithKline. Founded in 1996, NeuroMetrix is headquartered in Woburn, Massachusetts.